A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy

Standard

A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy. / Tomas, Nicola M; Meyer-Schwesinger, Catherine; von Spiegel, Hanning; Kotb, Ahmed M; Zahner, Gunther; Hoxha, Elion; Helmchen, Udo; Endlich, Nicole; Koch-Nolte, Friedrich; Stahl, Rolf A K.

In: J AM SOC NEPHROL, Vol. 28, No. 11, 11.2017, p. 3262-3277.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{18b095f65aa44c48949dad3c753b882a,
title = "A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy",
abstract = "Thrombospondin type 1 domain-containing 7A (THSD7A) is a target for autoimmunity in patients with membranous nephropathy (MN). Circulating autoantibodies from patients with THSD7A-associated MN have been demonstrated to cause MN in mice. However, THSD7A-associated MN is a rare disease, preventing the use of patient antibodies for larger experimental procedures. Therefore, we generated antibodies against the human and mouse orthologs of THSD7A in rabbits by coimmunization with the respective cDNAs. Injection of these anti-THSD7A antibodies into mice induced a severe nephrotic syndrome with proteinuria, weight gain, and hyperlipidemia. Immunofluorescence analyses revealed granular antigen-antibody complexes in a subepithelial location along the glomerular filtration barrier 14 days after antibody injection, and immunohistochemistry for rabbit IgG and THSD7A as well as ultrastructural analyses showed the typical characteristics of human MN. Mice injected with purified IgG from rabbit serum that was taken before immunization failed to develop any of these changes. Notably, MN developed in the absence of detectable complement activation, and disease was strain dependent. In vitro, anti-THSD7A antibodies caused cytoskeletal rearrangement and activation of focal adhesion signaling. Knockdown of the THSD7A ortholog, thsd7aa, in zebrafish larvae resulted in altered podocyte differentiation and impaired glomerular filtration barrier function, with development of pericardial edema, suggesting an important role of THSD7A in glomerular filtration barrier integrity. In summary, our study introduces a heterologous mouse model that allows further investigation of the molecular events that underlie MN.",
keywords = "Animals, Antibodies, Antigens, Surface, Disease Models, Animal, Glomerulonephritis, Membranous, Humans, Male, Membrane Proteins, Mice, Mice, Inbred BALB C, Rabbits, Rats, Rats, Sprague-Dawley, Thrombospondins, Journal Article",
author = "Tomas, {Nicola M} and Catherine Meyer-Schwesinger and {von Spiegel}, Hanning and Kotb, {Ahmed M} and Gunther Zahner and Elion Hoxha and Udo Helmchen and Nicole Endlich and Friedrich Koch-Nolte and Stahl, {Rolf A K}",
note = "Copyright {\textcopyright} 2017 by the American Society of Nephrology.",
year = "2017",
month = nov,
doi = "10.1681/ASN.2017010030",
language = "English",
volume = "28",
pages = "3262--3277",
journal = "J AM SOC NEPHROL",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "11",

}

RIS

TY - JOUR

T1 - A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy

AU - Tomas, Nicola M

AU - Meyer-Schwesinger, Catherine

AU - von Spiegel, Hanning

AU - Kotb, Ahmed M

AU - Zahner, Gunther

AU - Hoxha, Elion

AU - Helmchen, Udo

AU - Endlich, Nicole

AU - Koch-Nolte, Friedrich

AU - Stahl, Rolf A K

N1 - Copyright © 2017 by the American Society of Nephrology.

PY - 2017/11

Y1 - 2017/11

N2 - Thrombospondin type 1 domain-containing 7A (THSD7A) is a target for autoimmunity in patients with membranous nephropathy (MN). Circulating autoantibodies from patients with THSD7A-associated MN have been demonstrated to cause MN in mice. However, THSD7A-associated MN is a rare disease, preventing the use of patient antibodies for larger experimental procedures. Therefore, we generated antibodies against the human and mouse orthologs of THSD7A in rabbits by coimmunization with the respective cDNAs. Injection of these anti-THSD7A antibodies into mice induced a severe nephrotic syndrome with proteinuria, weight gain, and hyperlipidemia. Immunofluorescence analyses revealed granular antigen-antibody complexes in a subepithelial location along the glomerular filtration barrier 14 days after antibody injection, and immunohistochemistry for rabbit IgG and THSD7A as well as ultrastructural analyses showed the typical characteristics of human MN. Mice injected with purified IgG from rabbit serum that was taken before immunization failed to develop any of these changes. Notably, MN developed in the absence of detectable complement activation, and disease was strain dependent. In vitro, anti-THSD7A antibodies caused cytoskeletal rearrangement and activation of focal adhesion signaling. Knockdown of the THSD7A ortholog, thsd7aa, in zebrafish larvae resulted in altered podocyte differentiation and impaired glomerular filtration barrier function, with development of pericardial edema, suggesting an important role of THSD7A in glomerular filtration barrier integrity. In summary, our study introduces a heterologous mouse model that allows further investigation of the molecular events that underlie MN.

AB - Thrombospondin type 1 domain-containing 7A (THSD7A) is a target for autoimmunity in patients with membranous nephropathy (MN). Circulating autoantibodies from patients with THSD7A-associated MN have been demonstrated to cause MN in mice. However, THSD7A-associated MN is a rare disease, preventing the use of patient antibodies for larger experimental procedures. Therefore, we generated antibodies against the human and mouse orthologs of THSD7A in rabbits by coimmunization with the respective cDNAs. Injection of these anti-THSD7A antibodies into mice induced a severe nephrotic syndrome with proteinuria, weight gain, and hyperlipidemia. Immunofluorescence analyses revealed granular antigen-antibody complexes in a subepithelial location along the glomerular filtration barrier 14 days after antibody injection, and immunohistochemistry for rabbit IgG and THSD7A as well as ultrastructural analyses showed the typical characteristics of human MN. Mice injected with purified IgG from rabbit serum that was taken before immunization failed to develop any of these changes. Notably, MN developed in the absence of detectable complement activation, and disease was strain dependent. In vitro, anti-THSD7A antibodies caused cytoskeletal rearrangement and activation of focal adhesion signaling. Knockdown of the THSD7A ortholog, thsd7aa, in zebrafish larvae resulted in altered podocyte differentiation and impaired glomerular filtration barrier function, with development of pericardial edema, suggesting an important role of THSD7A in glomerular filtration barrier integrity. In summary, our study introduces a heterologous mouse model that allows further investigation of the molecular events that underlie MN.

KW - Animals

KW - Antibodies

KW - Antigens, Surface

KW - Disease Models, Animal

KW - Glomerulonephritis, Membranous

KW - Humans

KW - Male

KW - Membrane Proteins

KW - Mice

KW - Mice, Inbred BALB C

KW - Rabbits

KW - Rats

KW - Rats, Sprague-Dawley

KW - Thrombospondins

KW - Journal Article

U2 - 10.1681/ASN.2017010030

DO - 10.1681/ASN.2017010030

M3 - SCORING: Journal article

C2 - 28814510

VL - 28

SP - 3262

EP - 3277

JO - J AM SOC NEPHROL

JF - J AM SOC NEPHROL

SN - 1046-6673

IS - 11

ER -